Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.
about
Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials.Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial.Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.
P2860
Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@en
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@nl
type
label
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@en
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@nl
prefLabel
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@en
Mammalian Target of Rapamycin ...... Kidney Transplant Recipients.
@nl
P2093
P2860
P50
P356
P1476
Mammalian Target of Rapamycin ...... t Kidney Transplant Recipients
@en
P2093
David W Johnson
Michael Burke
Philip A Clayton
Scott B Campbell
Stephen P McDonald
P2860
P304
P356
10.2215/CJN.00190116
P577
2016-07-21T00:00:00Z